The main thing I remember about January 2020 was the rain and the number of times I was stranded at railway stations as the tracks were washed away. A few weeks later, like all of us, I would have been grateful if it was just the weather that was bothering me. The rest of 2020 feels like a blur, but a blur of activity and delivery and pressure to move faster.
Andy Jones has recently been appointed as ISCF Medicines Manufacturing Challenge Director. Andy has more than 30 years’ experience in development and manufacturing in the pharmaceutical industry took up his position in October.
The challenge seeks to dramatically enhance the pace of development, manufacture and delivery of novel medicines in the UK and thus to increase the rate at which patients can access new medicines.
Andy has held a number of senior positions during his career, and has been responsible for Chemistry, Manufacturing and Control (CMC) development of multibillion dollar products in the fields of oncology, neuroscience and cardiovascular and metabolic disease.
Latterly while leading Pharmaceutical Innovation and Manufacturing Science and Technology in AstraZeneca he has driven advances in modelling and simulation, digital therapeutics and advanced manufacturing technologies.
Dr Jones has a PhD in organic chemistry from the University of Wales Institute of Science and Technology and joined the pharmaceutical industry following a period of postdoctoral research at the University of Colorado.
It’s about a year now since the Industrial Strategy Challenge Fund medicines manufacturing challenge started to fund its first projects. Twelve months on, great progress has been made with much more to come in 2019. This is great news for …
Related content and links
About Innovate UK
A blog on the work of Innovate UK. Contributors are Innovate UK staff and our wider family, partners and experts from the world of innovation.